Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia.
Barone-Rochette G, Vanzetto G, Danchin N, Steg PG, Hanon O, Charlon C, David-Tchouda S, Gavazzi G, Simon T, Bosson JL; EVAOLD study investigator. Barone-Rochette G, et al. Among authors: danchin n. Am Heart J. 2025 Jan;279:94-103. doi: 10.1016/j.ahj.2024.10.013. Epub 2024 Oct 23. Am Heart J. 2025. PMID: 39447717 Clinical Trial.
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial.
Puymirat E, Soulat G, Fayol A, Mousseaux E, Montalescot G, Cayla G, Steg PG, Berard L, Rousseau A, Drouet É, Simon T, Danchin N; APERITIF study investigators. Puymirat E, et al. Among authors: danchin n. Am Heart J. 2023 Dec;266:98-105. doi: 10.1016/j.ahj.2023.09.005. Epub 2023 Sep 14. Am Heart J. 2023. PMID: 37716448 Clinical Trial.
Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
Puymirat E, Simon T, de Bruyne B, Montalescot G, Steg G, Cayla G, Durand-Zaleski I, Blanchard D, Danchin N, Chatellier G; FLOWER-MI study investigators. Puymirat E, et al. Among authors: danchin n. Am Heart J. 2020 Apr;222:1-7. doi: 10.1016/j.ahj.2019.12.015. Epub 2019 Dec 27. Am Heart J. 2020. PMID: 32000067 Clinical Trial.
Beware of simple explanations.
Simon T, Danchin N. Simon T, et al. Among authors: danchin n. Heart. 2021 Mar;107(5):348-349. doi: 10.1136/heartjnl-2020-317605. Epub 2020 Nov 4. Heart. 2021. PMID: 33148546 No abstract available.
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses.
Durand-Zaleski I, Ducrocq G, Mimouni M, Frenkiel J, Avendano-Solá C, Gonzalez-Juanatey JR, Ferrari E, Lemesle G, Puymirat E, Berard L, Cachanado M, Arnaiz JA, Martínez-Sellés M, Silvain J, Ariza-Solé A, Calvo G, Danchin N, Paco S, Drouet E, Abergel H, Rousseau A, Simon T, Steg PG. Durand-Zaleski I, et al. Among authors: danchin n. Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):194-202. doi: 10.1093/ehjqcco/qcac029. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 35612990 Clinical Trial.
Impact of transfusion strategy on platelet aggregation and biomarkers in myocardial infarction patients with anemia.
Silvain J, Lattuca B, Puymirat E, Ducrocq G, Dillinger JG, Lhermusier T, Procopi N, Cachanado M, Drouet E, Abergel H, Danchin N, Montalescot G, Simon T, Steg PG. Silvain J, et al. Among authors: danchin n. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):647-657. doi: 10.1093/ehjcvp/pvad055. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37609995 Clinical Trial.
865 results